Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorders”

14,127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,127 results

Large-scale testing (Phase 3)Looking for participantsNCT06051617
What this trial is testing

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Who this might be right for
Primary Biliary Cholangitis
Gilead Sciences 318
Testing effectiveness (Phase 2)Study completedNCT03863574
What this trial is testing

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Zydus Therapeutics Inc. 16
Not applicableUnknownNCT00730860
What this trial is testing

Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE

Who this might be right for
Cancer of Liver
Southwest Hospital, China 140
Post-approval studies (Phase 4)Active Not RecruitingNCT04032860
What this trial is testing

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

Who this might be right for
HCCHBV Coinfection
West China Hospital 104
Post-approval studies (Phase 4)Study completedNCT00338780
What this trial is testing

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong
Testing effectiveness (Phase 2)WithdrawnNCT04105062
What this trial is testing

LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery

Who this might be right for
Pancreatic CancerLiver CancerGastric Cancer+2 more
Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT00433069
What this trial is testing

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

Who this might be right for
Chronic Hepatitis C
University Hospital, Geneva 5
Not applicableLooking for participantsNCT04681573
What this trial is testing

Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD

Who this might be right for
NAFLD
University Hospital, Angers 1,045
Not applicableUnknownNCT02238769
What this trial is testing

18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 80
Post-approval studies (Phase 4)Ended earlyNCT02429583
What this trial is testing

Effects of Persistent Innate Immune Activation on Vaccine Efficacy

Who this might be right for
Hepatitis C Infection
Rockefeller University 24
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Not applicableWithdrawnNCT01691235
What this trial is testing

SIMpill Medication Dispensing Device in the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT01935635
What this trial is testing

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 400
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Not applicableUnknownNCT03753308
What this trial is testing

Mechanism of DCs Dysfunction in Chronic HBV Infection

Who this might be right for
HBVNASH - Nonalcoholic Steatohepatitis
University Hospital, Grenoble 132
Not applicableLooking for participantsNCT07321925
What this trial is testing

Thermoacoustic Method for Estimating Liver Fat Fraction

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Fatty Liver Disease, Nonalcoholic
Endra Lifesciences 49
Not applicableNot Yet RecruitingNCT07473817
What this trial is testing

Validation of Different Methods for HepQuant DuO® Blood Sample Collection

Who this might be right for
Healthy Adult ParticipantsLiver Disease Chronic
HepQuant, LLC 200
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Not applicableUnknownNCT01169168
What this trial is testing

Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)

Who this might be right for
SIRSSepsisLiver Disease
Johann Wolfgang Goethe University Hospital 250
Not applicableUnknownNCT03337074
What this trial is testing

Paternally Inherited Phenotypes in Cholestasis

Who this might be right for
CholestasisPrimary Sclerosing CholangitisPrimary Biliary Cirrhosis
Guy's and St Thomas' NHS Foundation Trust 200
Load More Results